Tag Archives: Compound Drug Recall

Featured Stories

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Tennessee Resident Files Pradaxa Bleeding Lawsuit Following Cerebral Hemorrhage

A man from Tennessee has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage. The complaint alleges Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause Serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects ...

Read More

Image Source: wisegeek.com

Trial over Ethicon Transvaginal Mesh Begins in California

Pelvic mesh devices have become the subject of safety concerns in recent years amidst reports that they can cause serious, sometimes permanent injuries.

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Senators promise action to prevent the next fungal meningitis outbreak

Lawmakers on Capitol Hill have promised to update federal regulations, namely with the Food and Drug Administration, that would bring pharmaceutical drug compounding labs under the agency’s eye in the future in hopes of avoiding situations like the current deadly … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Product Recalls | Tagged , , |

Skepticism of company at center of fungal meningitis outbreak continues to grow

The company at the center of the deadly fungal meningitis outbreak has been under increased oversight since a 2006 inspection of its pharmacy labs discovered widespread deficiencies in protocols for manufacturing drugs. According to an AP report, New England Compounding … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , |

Meningitis outbreak toll now at 205 sick, 14 dead

Federal health officials have drastically increased the amount of confirmed cases of fungal meningitis linked to the use of a contaminated vial of an epidural steroid drug injection. According to Reuters, the Centers for Disease Control and Prevention this weekend … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , |

Another death, more infections reported in fungal meningitis outbreak

Health officials are reporting another death, the twelfth, and more illnesses in the outbreak of fungal meningitis linked to a contaminated epidural steroid injection. According to a recent update from MedPageToday.com and other sources, the Centers for Disease Control and … Continue reading

Posted in Pharmaceuticals | Tagged , |

State regulator, pharmaceutical executive cloud picture on fungal meningitis outbreak

A sitting member of Massachusetts’ regulatory agency that oversees pharmaceutical safety has a direct link to the company implicated in the nationwide outbreak of fungal meningitis. According to a Boston Globe report this week, Sophia Pasedis has recused herself from … Continue reading

Posted in Pharmaceuticals | Tagged , , |

Franck’s Pharmacy Expands Recall Of Compounded Drugs

Franck’s Pharmacy just expanded its recall of compounded drugs, the U.S. Food & Drug Administration (FDA) just announced. Compounding involves mixing drugs using bulk ingredients, typically when patients are allergic to inactive ingredients in medicines approved by the FDA or … Continue reading

Posted in Pharmaceuticals | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.